Delivery Order SPE2DX22D0099-SPE2D826FAF2X
- Not listed
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,038.96 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is not set aside for any specific business category and has an ultimate completion date of January 8, 2026. The award represents a child task order under AmerSourceBergen's parent company...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,855.62 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was competitively awarded with no set-aside designation. The contract will be performed in Conshohocken, Pennsylvania, where AmerSourceBergen Drug Corp maintains its corporate office. This delivery order...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,643.25 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, which has an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $22,525.30 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is to be performed in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates as a subsidiary of parent...
- On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,276.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,293.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 6, 2026. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- On January 8, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $164,285.28 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with a corporate office location in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which carries an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerSourceBergen), a major...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,138.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed in Conshohocken, Pennsylvania. The award represents a task order against AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- On January 6, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,374.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (Doing Business As AmerSourceBergen). This firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion on January 7, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAF2XDelivery Order
On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $914,381.09 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for ultimate completion by January 9, 2026. AmerSourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor serving critical federal healthcare procurement needs. The delivery order represents task work under a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. AmerSourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and federal healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized therapeutic commodities across multiple treatment domains. The company's extensive federal contract activity demonstrates its capability to fulfill diverse medical procurement requirements through open competition. The parent company, Cencora, Inc., holds additional significant IDCs with federal agencies including the Department of Veterans Affairs and the Federal Bureau of Investigation, further establishing its role as a critical vendor in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $914.4k | 1/7/26 |